Histone deacetylase inhibitors: clinical implications for hematological malignancies

nork Tambaro, Francesco Paolo, Dell’Aversana, Carmela, Carafa, Vincenzo, Nebbioso, Angela, Radic, Branka, Ferrara, Felicetto, Altucci, Lucia
Argitaratua 2010

The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cells

nork Franci, Gianluigi, Casalino, Laura, Petraglia, Francesca, Miceli, Marco, Menafra, Roberta, Radic, Branka, Tarallo, Valeria, Vitale, Monica, Scarfò, Marzia, Pocsfalvi, Gabriella, Baldi, Alfonso, Ambrosino, Concetta, Zambrano, Nicola, Patriarca, Eduardo, De Falco, Sandro, Minchiotti, Gabriella, Stunnenberg, Hendrik G., Altucci, Lucia
Argitaratua 2013

The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity

nork Winter, Georg E., Radic, Branka, Mayor-Ruiz, Cristina, Blomen, Vincent A, Trefzer, Claudia, Kandasamy, Richard K., Huber, Kilian V.M., Gridling, Manuela, Chen, Doris, Klampfl, Thorsten, Kralovics, Robert, Kubicek, Stefan, Fernandez-Capetillo, Oscar, Brummelkamp, Thijn R., Superti-Furga, Giulio
Argitaratua izan da Nat Chem Biol (2014)

Stereospecific targeting of MTH1 by (S)-crizotinib as anticancer strategy

nork Huber, Kilian V. M., Salah, Eidarus, Radic, Branka, Gridling, Manuela, Elkins, Jonathan M., Stukalov, Alexey, Jemth, Ann-Sofie, Gokturk, Camilla, Sanjiv, Kumar, Strömberg, Kia, Pham, Therese, Berglund, Ulrika Warpman, Colinge, Jacques, Bennett, Keiryn L., Loizou, Joanna, Helleday, Thomas, Knapp, Stefan, Superti-Furga, Giulio
Argitaratua 2014